Sole Source Compounded IV Fluids

The Defense Health Agency is intending to award a sole source BPA for compounded IV fluids, including TPN solutions, to Central Admixture Pharmacy Services, Inc.

DEFENSE HEALTH AGENCY (DHA)

General

Status:Open (active)

Solicitation Identifier:HT941026N0069

Due Date:Jun 30, 2026 05:00 PM

Posted Date:Jun 15, 2026 08:54 PM

Contract Period:1 year base + 4 × 1 year options

Type:Sole Source

Level:Federal

Original Solicitation Links

[

HT941026N0069

]

sole source total parenteral nutrition (tpn) solutions, including trophamine, plenamine, nutrilipid, and smof lipid same-day delivery, seven days a week

Contact

Name:Cha-on P. Gordon

Phone:+17262030109

Submission Instructions

Method:Capability Statement Submission (Sole Source Challenge Window/Information Gathering for Sole Source Award Decision Process) or Direct Response to Sole Source Intent Notice for Information Gathering Purposes. Note: The solicitation states 'Sources interested in responding to this notice are required to submit a capability statement...' and 'If a vendor challenges the basis of this requirement, please email capability statements...'. This is not a standard bid submission but a response to a Sole Source notice for potential challenges or to provide capability information regarding the sole source intent. The direct email address is provided for this purpose, thus 'email' type with a specified email address is most appropriate for submitting the capability statement for consideration or challenge purposes. However, the instructions from the solicitation itself are to submit capability statements, not a bid or proposal in response to an open competition. The prompt instructions for submission_information are to capture how to submit a proposal. Since this is not a proposal, but a capability statement in response to a sole source notice, the best fit is 'other' with an explanation. The solicitation mentions emailing capability statements to the Contract Specialist as the deadline for challenges. Therefore, the 'email' type would be appropriate if the intent was to submit a capability statement, but the intent for this field is to capture proposal submission method. Since there is no open competition, there is no proposal submission method to capture. The solicitation states that 'no solicitation document exists for this requirement.' Therefore, no proposal submission is possible. However, if a vendor wishes to challenge the basis of this requirement, they must submit capability statements. The email address provided is for this purpose. Given the nuanced nature, 'other' with an explanation is the safest choice, but 'email' with the provided address is also a reasonable interpretation if interpreted as the method for submitting any response to the notice. Given the prompt's emphasis on 'proposal submission', and the fact that this is not a proposal submission, 'other' is the most accurate choice. The instructions say if no submission info is provided, leave it null. If it is federal, assume SAM.GOV. This is federal, but explicitly directs responses via email for challenges/capability statements. Thus, it is not null, and it is not SAM.GOV. The most accurate representation of how to respond to the notice, as per the document, is to email a capability statement. Therefore, 'email' type is selected, with the email address provided for challenges/responses. The extra instructions are to clarify the nature of the response (capability statement, not a bid) and the deadline. The deadline is 'not later than 10:00 a.m. (Pacific), Tuesday June 30, 2026'. The prompt states 'never include award process, evaluation criteria, reservation-of-rights / cancellation language, contact-for-questions details, or anything already captured in another field (email_address, mail_address, online_portal_url).'.

Description

The Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division-West (HCD-W), intends to award a firm-fixed-price five (5)-year Blanket Purchase Agreement (BPA) for compounded intravenous (IV) fluids, cardioplegic solutions, and specialized Total Parenteral Nutrition (TPN) solutions, including TrophAmine, Plenamine, Nutrilipid, and SMOFLipid. These critical and time-sensitive products must be available for ordering and guaranteed same-day delivery, seven days a week. Market research conducted in accordance with Federal Acquisition Regulation (FAR) Part 10 determined that Central Admixture Pharmacy Services, Inc. is the only source capable of meeting the agency's strict delivery and formulary requirements. While pre-mixed IV fluids are commercially available, only Central Admixture Pharmacy Services, Inc. can meet the specialized needs of the Madigan Army Medical Center's Nuclear Medicine Division. The North American Industry Classification System (NAICS) code for this requirement is 325412 - Pharmaceutical Preparation Manufacturing, with a business size standard of 1,300 employees. The Product Service Code (PSC) is 6505-DrugsandBiologicalsProducts.